Procept Biorobotics's (PRCT) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Procept Biorobotics Corporation  (NASDAQ: PRCT)
 



  Procept Biorobotics Corporation Outlook

On October 28 2024 the Procept Biorobotics Corporation provided following guidance

nnPROCEPT BioRobotics Corporation Announces Third Quarter 2024 Financial Results and Raises Revenue and Adjusted EBITDA Outlook for the Yearnn

nnSAN JOSE, Calif., October 28, 2024nn – PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a pioneering company in the field of surgical robotics dedicated to enhancing patient care through innovative urological solutions, has released its unaudited financial results for the third quarter of 2024, concluding on September 30, 2024.

In this latest update, the company has revealed that it is adjusting its projections for 2024, increasing both its anticipated revenue and adjusted EBITDA figures. While specific numbers were not disclosed in this communication, the revisions reflect the company's strong performance and confidence in its growth trajectory.

As PROCEPT BioRobotics continues to advance its mission in the urology sector, the positive revisions in financial guidance underscore its commitment to delivering transformative solutions that enhance surgical outcomes and improve patient experiences. Further details about the company's financial performance and future outlook are expected to be shared as part of ongoing communications with stakeholders.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.